OCT Biomarkers May Predict Retinal Atrophy Risk in nAMD Patients: Study Jacinthlyn Sylvia30 May 2025 9:15 PM ISTA new study published in the International Journal of Ophthalmology showed specific optical coherence tomography (OCT) features (type 2 macular...
Bayer-Regeneron Eylea 8 mg approved in China for wet age-related macular degeneration Ruchika Sharma22 May 2025 3:30 PM ISTBerlin: Bayer has received approval from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for Eylea 8...
Intas Pharmaceuticals Gets CDSCO Panel Nod To study Bevacizumab Solution for Injection Dr. Divya Colin12 March 2025 5:45 PM ISTNew Delhi: Intas Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Safety of Lupin's Ranibizumab (Ranieyes) established in Large-Scale Multicenter Study with 2194 injections in 1401 eyes MDTV Bureau6 Dec 2024 12:19 PM ISTReal-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab (Ranieyes) is a safe...
Faricimab reduces fluid in Neovascular Age-Related Macular Degeneration eyes, unravels study Dr Ishan Kataria12 Nov 2024 8:00 PM ISTAge-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 years old. ...
Sun Pharmaceutical Industry gets CDSCO Panel nod to study Aflibercept Injection Dr. Divya Colin6 Oct 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has granted approval to the drug...
Lupin Announces Positive Results from Global Phase 3 Trial of Lucentis Biosimilar Lalhmangaihkimi8 Aug 2024 10:46 AM ISTLupin recently announced positive results from global phase 3 clinical trials evaluating the immunogenicity, safety, and efficacy of LUBT010—Lupin's...
Lupin completes Phase 3 trials for Lucentis biosimilar Ruchika Sharma6 Aug 2024 4:30 PM ISTMumbai: Global Pharma major Lupin Limited has announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar...
Stereotactic Radiotherapy Reduces Anti-VEGF Use in nAMD Without Affecting Visual Acuity: Study Dr Riya Dave19 Jun 2024 9:00 PM ISTResearchers have found that stereotactic radiotherapy (SRT) for neovascular age-related macular degeneration (nAMD) reduces the need for anti-vascular...
Biocon Biologics forays into US Ophthalmology market with USFDA nod for Yesafili Ruchika Sharma21 May 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, today announced that the U.S....
Home-monitoring tests lack satisfactory diagnostic accuracy to identify neovascular age-related macular degeneration:JAMA Jacinthlyn Sylvia5 May 2024 8:00 PM ISTA recent study found home-monitoring tests as a potential solution to reduce the burden of neovascular age-related macular degeneration (nAMD) on...
VEGF inhibitors may reduce all-cause mortality in nAMD patients Jacinthlyn Sylvia14 Feb 2024 7:00 PM ISTA recent study published in the Ophthalmology Science, assessed the safety concerns surrounding intravitreal VEGF inhibitors in the treatment of...
